Table of Content

1 Study Coverage
1.1 Androgen and Anabolic Steroid Product Introduction
1.2 Market by Type
1.2.1 Global Androgen and Anabolic Steroid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Testosterone
1.2.3 Methyltestosterone
1.2.4 Fluoxymesterone
1.2.5 Others
1.3 Market by Application
1.3.1 Global Androgen and Anabolic Steroid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Androgen and Anabolic Steroid Sales Estimates and Forecasts 2018-2029
2.2 Global Androgen and Anabolic Steroid Revenue by Region
2.2.1 Global Androgen and Anabolic Steroid Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Androgen and Anabolic Steroid Revenue by Region (2018-2024)
2.2.3 Global Androgen and Anabolic Steroid Revenue by Region (2024-2029)
2.2.4 Global Androgen and Anabolic Steroid Revenue Market Share by Region (2018-2029)
2.3 Global Androgen and Anabolic Steroid Sales Estimates and Forecasts 2018-2029
2.4 Global Androgen and Anabolic Steroid Sales by Region
2.4.1 Global Androgen and Anabolic Steroid Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Androgen and Anabolic Steroid Sales by Region (2018-2024)
2.4.3 Global Androgen and Anabolic Steroid Sales by Region (2024-2029)
2.4.4 Global Androgen and Anabolic Steroid Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Androgen and Anabolic Steroid Sales by Manufacturers
3.1.1 Global Androgen and Anabolic Steroid Sales by Manufacturers (2018-2024)
3.1.2 Global Androgen and Anabolic Steroid Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Androgen and Anabolic Steroid in 2022
3.2 Global Androgen and Anabolic Steroid Revenue by Manufacturers
3.2.1 Global Androgen and Anabolic Steroid Revenue by Manufacturers (2018-2024)
3.2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Androgen and Anabolic Steroid Revenue in 2022
3.3 Global Key Players of Androgen and Anabolic Steroid, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Androgen and Anabolic Steroid Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Androgen and Anabolic Steroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Androgen and Anabolic Steroid, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Androgen and Anabolic Steroid, Product Offered and Application
3.8 Global Key Manufacturers of Androgen and Anabolic Steroid, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Androgen and Anabolic Steroid Sales by Type
4.1.1 Global Androgen and Anabolic Steroid Historical Sales by Type (2018-2024)
4.1.2 Global Androgen and Anabolic Steroid Forecasted Sales by Type (2024-2029)
4.1.3 Global Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
4.2 Global Androgen and Anabolic Steroid Revenue by Type
4.2.1 Global Androgen and Anabolic Steroid Historical Revenue by Type (2018-2024)
4.2.2 Global Androgen and Anabolic Steroid Forecasted Revenue by Type (2024-2029)
4.2.3 Global Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
4.3 Global Androgen and Anabolic Steroid Price by Type
4.3.1 Global Androgen and Anabolic Steroid Price by Type (2018-2024)
4.3.2 Global Androgen and Anabolic Steroid Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Androgen and Anabolic Steroid Sales by Application
5.1.1 Global Androgen and Anabolic Steroid Historical Sales by Application (2018-2024)
5.1.2 Global Androgen and Anabolic Steroid Forecasted Sales by Application (2024-2029)
5.1.3 Global Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
5.2 Global Androgen and Anabolic Steroid Revenue by Application
5.2.1 Global Androgen and Anabolic Steroid Historical Revenue by Application (2018-2024)
5.2.2 Global Androgen and Anabolic Steroid Forecasted Revenue by Application (2024-2029)
5.2.3 Global Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
5.3 Global Androgen and Anabolic Steroid Price by Application
5.3.1 Global Androgen and Anabolic Steroid Price by Application (2018-2024)
5.3.2 Global Androgen and Anabolic Steroid Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Androgen and Anabolic Steroid Market Size by Type
6.1.1 US & Canada Androgen and Anabolic Steroid Sales by Type (2018-2029)
6.1.2 US & Canada Androgen and Anabolic Steroid Revenue by Type (2018-2029)
6.2 US & Canada Androgen and Anabolic Steroid Market Size by Application
6.2.1 US & Canada Androgen and Anabolic Steroid Sales by Application (2018-2029)
6.2.2 US & Canada Androgen and Anabolic Steroid Revenue by Application (2018-2029)
6.3 US & Canada Androgen and Anabolic Steroid Market Size by Country
6.3.1 US & Canada Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Androgen and Anabolic Steroid Sales by Country (2018-2029)
6.3.3 US & Canada Androgen and Anabolic Steroid Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Androgen and Anabolic Steroid Market Size by Type
7.1.1 Europe Androgen and Anabolic Steroid Sales by Type (2018-2029)
7.1.2 Europe Androgen and Anabolic Steroid Revenue by Type (2018-2029)
7.2 Europe Androgen and Anabolic Steroid Market Size by Application
7.2.1 Europe Androgen and Anabolic Steroid Sales by Application (2018-2029)
7.2.2 Europe Androgen and Anabolic Steroid Revenue by Application (2018-2029)
7.3 Europe Androgen and Anabolic Steroid Market Size by Country
7.3.1 Europe Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Androgen and Anabolic Steroid Sales by Country (2018-2029)
7.3.3 Europe Androgen and Anabolic Steroid Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Androgen and Anabolic Steroid Market Size
8.1.1 China Androgen and Anabolic Steroid Sales (2018-2029)
8.1.2 China Androgen and Anabolic Steroid Revenue (2018-2029)
8.2 China Androgen and Anabolic Steroid Market Size by Application
8.2.1 China Androgen and Anabolic Steroid Sales by Application (2018-2029)
8.2.2 China Androgen and Anabolic Steroid Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Androgen and Anabolic Steroid Market Size by Type
9.1.1 Asia Androgen and Anabolic Steroid Sales by Type (2018-2029)
9.1.2 Asia Androgen and Anabolic Steroid Revenue by Type (2018-2029)
9.2 Asia Androgen and Anabolic Steroid Market Size by Application
9.2.1 Asia Androgen and Anabolic Steroid Sales by Application (2018-2029)
9.2.2 Asia Androgen and Anabolic Steroid Revenue by Application (2018-2029)
9.3 Asia Androgen and Anabolic Steroid Sales by Region
9.3.1 Asia Androgen and Anabolic Steroid Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Androgen and Anabolic Steroid Revenue by Region (2018-2029)
9.3.3 Asia Androgen and Anabolic Steroid Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Androgen and Anabolic Steroid Market Size by Type
10.1.1 Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Androgen and Anabolic Steroid Market Size by Application
10.2.1 Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Country
10.3.1 Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Auxilium Pharmaceuticals
11.1.1 Auxilium Pharmaceuticals Company Information
11.1.2 Auxilium Pharmaceuticals Overview
11.1.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Auxilium Pharmaceuticals Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Overview
11.2.3 AbbVie Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 AbbVie Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AbbVie Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 GlaxoSmithKline Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Endo Pharmaceuticals
11.5.1 Endo Pharmaceuticals Company Information
11.5.2 Endo Pharmaceuticals Overview
11.5.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Endo Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Pfizer Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Acerus Pharmaceuticals
11.7.1 Acerus Pharmaceuticals Company Information
11.7.2 Acerus Pharmaceuticals Overview
11.7.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Acerus Pharmaceuticals Recent Developments
11.8 Antares Pharma
11.8.1 Antares Pharma Company Information
11.8.2 Antares Pharma Overview
11.8.3 Antares Pharma Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Antares Pharma Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Antares Pharma Recent Developments
11.9 Amneal Pharmaceuticals
11.9.1 Amneal Pharmaceuticals Company Information
11.9.2 Amneal Pharmaceuticals Overview
11.9.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Amneal Pharmaceuticals Recent Developments
11.10 Solvay Pharmaceuticals
11.10.1 Solvay Pharmaceuticals Company Information
11.10.2 Solvay Pharmaceuticals Overview
11.10.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Solvay Pharmaceuticals Recent Developments
11.11 Bausch Health
11.11.1 Bausch Health Company Information
11.11.2 Bausch Health Overview
11.11.3 Bausch Health Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Bausch Health Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bausch Health Recent Developments
11.12 Pharmacia and Upjohn
11.12.1 Pharmacia and Upjohn Company Information
11.12.2 Pharmacia and Upjohn Overview
11.12.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pharmacia and Upjohn Recent Developments
11.13 Upsher-Smith
11.13.1 Upsher-Smith Company Information
11.13.2 Upsher-Smith Overview
11.13.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Upsher-Smith Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Upsher-Smith Recent Developments
11.14 Clarus Therapeutics
11.14.1 Clarus Therapeutics Company Information
11.14.2 Clarus Therapeutics Overview
11.14.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Clarus Therapeutics Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Clarus Therapeutics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Androgen and Anabolic Steroid Industry Chain Analysis
12.2 Androgen and Anabolic Steroid Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Androgen and Anabolic Steroid Production Mode & Process
12.4 Androgen and Anabolic Steroid Sales and Marketing
12.4.1 Androgen and Anabolic Steroid Sales Channels
12.4.2 Androgen and Anabolic Steroid Distributors
12.5 Androgen and Anabolic Steroid Customers
13 Market Dynamics
13.1 Androgen and Anabolic Steroid Industry Trends
13.2 Androgen and Anabolic Steroid Market Drivers
13.3 Androgen and Anabolic Steroid Market Challenges
13.4 Androgen and Anabolic Steroid Market Restraints
14 Key Findings in The Global Androgen and Anabolic Steroid Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Androgen and Anabolic Steroid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Testosterone
Table 3. Major Manufacturers of Methyltestosterone
Table 4. Major Manufacturers of Fluoxymesterone
Table 5. Major Manufacturers of Others
Table 6. Global Androgen and Anabolic Steroid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Androgen and Anabolic Steroid Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Androgen and Anabolic Steroid Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2018-2024)
Table 11. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2024-2029)
Table 12. Global Androgen and Anabolic Steroid Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Androgen and Anabolic Steroid Sales by Region (2018-2024) & (K Units)
Table 14. Global Androgen and Anabolic Steroid Sales by Region (2024-2029) & (K Units)
Table 15. Global Androgen and Anabolic Steroid Sales Market Share by Region (2018-2024)
Table 16. Global Androgen and Anabolic Steroid Sales Market Share by Region (2024-2029)
Table 17. Global Androgen and Anabolic Steroid Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Androgen and Anabolic Steroid Sales Share by Manufacturers (2018-2024)
Table 19. Global Androgen and Anabolic Steroid Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Androgen and Anabolic Steroid Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Androgen and Anabolic Steroid, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Androgen and Anabolic Steroid Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Androgen and Anabolic Steroid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Androgen and Anabolic Steroid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen and Anabolic Steroid as of 2022)
Table 25. Global Key Manufacturers of Androgen and Anabolic Steroid, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Androgen and Anabolic Steroid, Product Offered and Application
Table 27. Global Key Manufacturers of Androgen and Anabolic Steroid, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 30. Global Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 31. Global Androgen and Anabolic Steroid Sales Share by Type (2018-2024)
Table 32. Global Androgen and Anabolic Steroid Sales Share by Type (2024-2029)
Table 33. Global Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Androgen and Anabolic Steroid Revenue Share by Type (2018-2024)
Table 36. Global Androgen and Anabolic Steroid Revenue Share by Type (2024-2029)
Table 37. Androgen and Anabolic Steroid Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Androgen and Anabolic Steroid Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 40. Global Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 41. Global Androgen and Anabolic Steroid Sales Share by Application (2018-2024)
Table 42. Global Androgen and Anabolic Steroid Sales Share by Application (2024-2029)
Table 43. Global Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Androgen and Anabolic Steroid Revenue Share by Application (2018-2024)
Table 46. Global Androgen and Anabolic Steroid Revenue Share by Application (2024-2029)
Table 47. Androgen and Anabolic Steroid Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Androgen and Anabolic Steroid Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 62. Europe Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 63. Europe Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 64. Europe Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 67. Europe Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 68. Europe Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 74. Europe Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 75. China Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 76. China Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 77. China Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 80. China Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 81. China Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 84. Asia Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 85. Asia Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 88. Asia Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 89. Asia Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Androgen and Anabolic Steroid Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Androgen and Anabolic Steroid Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Androgen and Anabolic Steroid Sales by Region (2018-2024) & (K Units)
Table 95. Asia Androgen and Anabolic Steroid Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales by Country (2024-2029) & (K Units)
Table 109. Auxilium Pharmaceuticals Company Information
Table 110. Auxilium Pharmaceuticals Description and Major Businesses
Table 111. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Auxilium Pharmaceuticals Recent Developments
Table 114. AbbVie Company Information
Table 115. AbbVie Description and Major Businesses
Table 116. AbbVie Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. AbbVie Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AbbVie Recent Developments
Table 119. Teva Company Information
Table 120. Teva Description and Major Businesses
Table 121. Teva Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Teva Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Teva Recent Developments
Table 124. GlaxoSmithKline Company Information
Table 125. GlaxoSmithKline Description and Major Businesses
Table 126. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. GlaxoSmithKline Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. GlaxoSmithKline Recent Developments
Table 129. Endo Pharmaceuticals Company Information
Table 130. Endo Pharmaceuticals Description and Major Businesses
Table 131. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Endo Pharmaceuticals Recent Developments
Table 134. Pfizer Company Information
Table 135. Pfizer Description and Major Businesses
Table 136. Pfizer Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Pfizer Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Pfizer Recent Developments
Table 139. Acerus Pharmaceuticals Company Information
Table 140. Acerus Pharmaceuticals Description and Major Businesses
Table 141. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Acerus Pharmaceuticals Recent Developments
Table 144. Antares Pharma Company Information
Table 145. Antares Pharma Description and Major Businesses
Table 146. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Antares Pharma Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Antares Pharma Recent Developments
Table 149. Amneal Pharmaceuticals Company Information
Table 150. Amneal Pharmaceuticals Description and Major Businesses
Table 151. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Amneal Pharmaceuticals Recent Developments
Table 154. Solvay Pharmaceuticals Company Information
Table 155. Solvay Pharmaceuticals Description and Major Businesses
Table 156. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Solvay Pharmaceuticals Recent Developments
Table 159. Bausch Health Company Information
Table 160. Bausch Health Description and Major Businesses
Table 161. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Bausch Health Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Bausch Health Recent Developments
Table 164. Pharmacia and Upjohn Company Information
Table 165. Pharmacia and Upjohn Description and Major Businesses
Table 166. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Pharmacia and Upjohn Recent Developments
Table 169. Upsher-Smith Company Information
Table 170. Upsher-Smith Description and Major Businesses
Table 171. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Upsher-Smith Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Upsher-Smith Recent Developments
Table 174. Clarus Therapeutics Company Information
Table 175. Clarus Therapeutics Description and Major Businesses
Table 176. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Clarus Therapeutics Androgen and Anabolic Steroid Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Clarus Therapeutics Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Androgen and Anabolic Steroid Distributors List
Table 182. Androgen and Anabolic Steroid Customers List
Table 183. Androgen and Anabolic Steroid Market Trends
Table 184. Androgen and Anabolic Steroid Market Drivers
Table 185. Androgen and Anabolic Steroid Market Challenges
Table 186. Androgen and Anabolic Steroid Market Restraints
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Androgen and Anabolic Steroid Product Picture
Figure 2. Global Androgen and Anabolic Steroid Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Androgen and Anabolic Steroid Market Share by Type in 2022 & 2029
Figure 4. Testosterone Product Picture
Figure 5. Methyltestosterone Product Picture
Figure 6. Fluoxymesterone Product Picture
Figure 7. Others Product Picture
Figure 8. Global Androgen and Anabolic Steroid Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Androgen and Anabolic Steroid Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Pharmacy
Figure 12. Others
Figure 13. Androgen and Anabolic Steroid Report Years Considered
Figure 14. Global Androgen and Anabolic Steroid Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Androgen and Anabolic Steroid Revenue 2018-2029 (US$ Million)
Figure 16. Global Androgen and Anabolic Steroid Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Androgen and Anabolic Steroid Revenue Market Share by Region (2018-2029)
Figure 18. Global Androgen and Anabolic Steroid Sales 2018-2029 ((K Units)
Figure 19. Global Androgen and Anabolic Steroid Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Androgen and Anabolic Steroid Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Androgen and Anabolic Steroid Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Androgen and Anabolic Steroid Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Androgen and Anabolic Steroid Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Androgen and Anabolic Steroid Sales YoY (2018-2029) & (K Units)
Figure 25. China Androgen and Anabolic Steroid Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Androgen and Anabolic Steroid Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Androgen and Anabolic Steroid Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Androgen and Anabolic Steroid Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Androgen and Anabolic Steroid in the World: Market Share by Androgen and Anabolic Steroid Revenue in 2022
Figure 32. Global Androgen and Anabolic Steroid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 34. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 35. Global Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 36. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Androgen and Anabolic Steroid Revenue Share by Country (2018-2029)
Figure 42. US & Canada Androgen and Anabolic Steroid Sales Share by Country (2018-2029)
Figure 43. U.S. Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 46. Europe Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 47. Europe Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 48. Europe Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 49. Europe Androgen and Anabolic Steroid Revenue Share by Country (2018-2029)
Figure 50. Europe Androgen and Anabolic Steroid Sales Share by Country (2018-2029)
Figure 51. Germany Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 52. France Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 56. China Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 57. China Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 58. China Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 59. China Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 60. Asia Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 61. Asia Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 62. Asia Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 63. Asia Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 64. Asia Androgen and Anabolic Steroid Revenue Share by Region (2018-2029)
Figure 65. Asia Androgen and Anabolic Steroid Sales Share by Region (2018-2029)
Figure 66. Japan Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 70. India Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Androgen and Anabolic Steroid Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Androgen and Anabolic Steroid Sales Share by Country (2018-2029)
Figure 77. Brazil Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Androgen and Anabolic Steroid Revenue (2018-2029) & (US$ Million)
Figure 82. Androgen and Anabolic Steroid Value Chain
Figure 83. Androgen and Anabolic Steroid Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed